Stayble Therapeutics AB Financial Overview
Stayble Therapeutics AB's market cap is currently €1.33M. The company's EPS TTM is €-0.0021022; its P/E ratio is -1.26; Stayble Therapeutics AB is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
